Qing Hua Chang Yin attenuates lipopolysaccharide-induced inflammatory response in human intestinal cells by inhibiting NF-κB activation

Experimental and Therapeutic Medicine

Volumn 6, Issue 1, 2013, Pages 189-193

  Ke, Xiao ^a   Chen, Jingtuan ^a   Zhang, Xin ^a   Fang, Wenyi ^a   Yang, Chunbo ^a   Peng, Jun ^a   Chen, Youqin ^b   Sferra, Thomas J ^b  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Inflammation; NF B pathway; Qing Hua Chang Yin; Traditional Chinese medicine; Ulcerative colitis

Indexed keywords

CHINESE DRUG; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; QING HUA CHANG YIN EXTRACT; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; INTESTINE CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 84878325779     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1071     Document Type: Article

References (29)

1. Rezaie A, Parker RD and Abdollahi M: Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 52: 2015-2021, 2007.
2. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
3. Odashima M, Otaka M, Jin M, et al: Successful treatment of refractory duodenal Crohn's disease with infliximab. Dig Dis Sci52: 31-32, 2007.
4. Treasure J: Herbal medicine and cancer: an introductory overview. Semin Oncol Nurs 21: 177-183, 2005.
5. Stickel F and Schuppan D: Herbal medicine in the treatment of liver diseases. Dig Liver Dis 39: 293-304, 2007.
6. Langmead L and Rampton DS: Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 23: 341-349, 2006.
7. Bensoussan M, Jovenin N, Garcia B, et al: Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. Gastroenterol Clin Biol 30: 14-23, 2006.
8. Caradonna L, Amati L, Magrone T, Pellegrino M, Jirillo E and Caccavo D: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6: 205-214, 2000.
9. Böcker U, Yezerskyy O, Feick P, et al: Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis 18: 25-32, 2003.
10. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA and Nusrat A: Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19: 923-933, 2005.
11. Schreiber S, Nikolaus S and Hampe J: Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484, 1998.
12. Andresen L, Jørgensen VL, Perner A, Hansen A, Eugen-Olsen;J and Rask-Madsen J: Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54: 503-509, 2005.
13. Lakatos PL, Fischer S, Lakatos L, et al: Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take 'toll'? World J Gastroenterol 12: 1829-1841, 2006.
14. Lu YC, Yeh WC and Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151, 2008.
15. Snape WJ Jr and Kao HW: Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis. Dig Dis Sci 33 (Suppl 3): 65S-70S, 1988.
16. Neuman MG: Immune dysfunction in inflammatory bowel disease. Transl Res 149: 173-186, 2007.
17. Eckmann L, Jung HC, Schürer-Maly C, Panja A, Morzycka-Wroblewska E and Kagnoff MF: Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterol 105: 1689-1697, 1993.
18. Wang D, DuBois RN and Richmond A: The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol 9: 688-696, 2009.
19. Brynskov J, Foegh P, Pedersen G, etal: Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 51: 37-43, 2002.
20. Wang XY and Tian DL: Etiological and pathological characteristics of ulcerative colitis and TCM differentiation and treatment. Beijing Zhong Yi Yao Da Xue Xue Bao 30: 554-559, 2007 (In Chinese).
21. Gong YP, Liu W, Ma GT, etal: Randomized control study of 'Qingchang Suppository' on ulcerative colitis. Shanghai Zhong Yi Yao Da Xue Xue Bao 21: 33-36, 2007 (In Chinese).
22. Fu NL and Huang JY: Progress of clinical research of traditional Chinese medicine for the treatment of ulcerative colitis. Journal of Traditional Chinese Medicine40: 501-503, 1999 (In Chinese).
23. Li QG: An idea about treatment of ulcerative colitis by TCM methods. Beijing Zhong Yi23: 149-150, 2004 (In Chinese).
24. Wang CH, Gao WY, Li YF, et al: Study of Fufangkushen colon-release capsule on ulcerative colitis of endo-retention of damp heat type. Xian Dai Zhong Xi Yi Jie He Za Zhi 18: 13-15, 2009 (In Chinese).
25. Chen JT, Ke X, Fu XY, et al: The clinical study of heat-clearing and damp-drying on the treatment of damp-heat ulcerative colitis. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi 17: 256-257, 2009 (In Chinese).
26. Kawai T and Akira S: TLR signaling. Cell Death Differ 13: 816-825, 2006.
27. Johnson GB, Brunn GJ, Kodaira Y and Platt JL: Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168: 5233-5239, 2002.
28. Lehnardt S, Schott E and Trimbuch T: A vicious cycle involving release of heat shock protein 60 from injured cells and activation of Toll-like receptor 4 mediates neurodegeneration in the CNS. J;Neurosci 28: 2320-2331, 2008.
29. Smiley ST, King JA and Hancock WW: Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J;Immunol 167: 2887-2894, 2001